Literature DB >> 7912884

Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency.

B C Byth1, G D Billingsley, D W Cox.   

Abstract

The alpha 1-antitrypsin (PI) gene is part of a cluster of structurally related serine protease inhibitor genes localized at chromosome 14q32.1, a cluster that includes the alpha 1-antichymotrypsin (AACT), protein C inhibitor (PCI), and corticosteroid-binding globulin (CBG) genes and the alpha 1-antitrypsin-like pseudogene (PIL). The order of the genes is refined here by genetic mapping using simple tandem repeat polymorphisms (STRPs) and by physical mapping in YACs. The order of the genes is (centromere)-CBG-PIL-PI-PCI-AACT-(telomere). Analysis of DNA haplotypes comprising STRP and RFLP markers in the serpin genes reveals considerable allelic association throughout the cluster. Furthermore, the common alpha 1-antitrypsin deficiency allele, PI*Z, has a unique DNA haplotype at the CBG, PIL, and PI loci, which extends over 60 kb in 97% of cases and in 44% of cases includes the PCI and AACT loci. This unique haplotype will be of use in examining a number of other diseases, particularly those with an inflammatory component, thought to be associated with alpha 1-antitrypsin deficiency or partial deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912884      PMCID: PMC1918218     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models.

Authors:  R C Lewontin
Journal:  Genetics       Date:  1964-01       Impact factor: 4.562

2.  Inference of recombinational hotspots using gametic disequilibrium values.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  1988-06       Impact factor: 3.821

3.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

4.  A (CA)n repeat polymorphism at the 5' end of the alpha 1-antitrypsin gene (PI).

Authors:  B C Byth; D W Cox
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

Review 5.  The serum transport of steroid hormones.

Authors:  P K Siiteri; J T Murai; G L Hammond; J A Nisker; W J Raymoure; R W Kuhn
Journal:  Recent Prog Horm Res       Date:  1982

6.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

7.  Cloning of the human alpha 1 antichymotrypsin gene and genetic analysis of the gene in relation to alpha 1 antitrypsin deficiency.

Authors:  G D Kelsey; D Abeliovich; C J McMahon; D Whitehouse; G Corney; S Povey; D A Hopkinson; J Wolfe; G Mieli-Vergani; A P Mowat
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

8.  Linkage disequilibrium between the juvenile neuronal ceroid lipofuscinosis gene and marker loci on chromosome 16p 12.1.

Authors:  T J Lerner; R M Boustany; K MacCormack; J Gleitsman; K Schlumpf; X O Breakefield; J F Gusella; J L Haines
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

9.  A (CA)n repeat polymorphism in the protein C inhibitor (PCI) gene.

Authors:  B C Byth; J C Meijers; D W Cox
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

10.  A physical map of the human PI and AACT genes.

Authors:  L Sefton; G Kelsey; P Kearney; S Povey; J Wolfe
Journal:  Genomics       Date:  1990-07       Impact factor: 5.736

View more
  8 in total

1.  Molecular linkage of the human alpha 1-antitrypsin and corticosteroid-binding globulin genes on chromosome 14q32.1.

Authors:  P Rollini; R E Fournier
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

Review 2.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

3.  Association between alpha-1 antichymotrypsin gene A/T polymorphism and primary intracerebral hemorrhage: a meta-analysis.

Authors:  Zusen Ye; Qiang Ye; Bei Shao; Jincai He; Zhenguo Zhu; Jianhua Cheng; Yanyan Chen; Siyan Chen; Xiaoya Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13

5.  Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis.

Authors:  Guangjian Yang; Jiangxia Yin; Kai Ou; Qiang Du; Wenhao Ren; Yujing Jin; Liming Peng; Lin Yang
Journal:  BMC Gastroenterol       Date:  2020-06-26       Impact factor: 3.067

Review 6.  Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.

Authors:  Frederick J de Serres
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

7.  Is Alpha-1 Antichymotrypsin Gene Polymorphism a Risk Factor for Primary Intracerebral Hemorrhage? A Case-Control Study and Meta-Analysis.

Authors:  Xin Hu; Yunke Li; Hao Li; Yuan Fang; Ming Liu; Chao You
Journal:  Med Sci Monit       Date:  2015-07-24

8.  hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency.

Authors:  Charis-Patricia Segeritz; Sheikh Tamir Rashid; Miguel Cardoso de Brito; Maria Paola Serra; Adriana Ordonez; Carola Maria Morell; Joseph E Kaserman; Pedro Madrigal; Nicholas R F Hannan; Laurent Gatto; Lu Tan; Andrew A Wilson; Kathryn Lilley; Stefan J Marciniak; Bibek Gooptu; David A Lomas; Ludovic Vallier
Journal:  J Hepatol       Date:  2018-06-05       Impact factor: 25.083

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.